Protection of androgen-dependent human prostate cancer cells from oxidative stress-induced DNA damage by overexpression of clusterin and its modulation by androgen

Prostate

Volumn 61, Issue 4, 2004, Pages 318-323

  Miyake, Hideaki ^a   Hara, Isao ^b   Gleave, Martin E ^c,d   Eto, Hiroshi ^a  

^a HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

Apoptosis; Clusterin; DNA damage; Oxidative stress

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; 8 HYDROXYDEOXYGUANOSINE; ANDROGEN; ANDROSTANOLONE; CLUSTERIN; HYDROGEN PEROXIDE; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DAMAGE; CELL PROTECTION; CELL STRUCTURE; CONTROLLED STUDY; DNA DAMAGE; DOSE RESPONSE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE VECTOR; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID PEROXIDATION; MEMBRANE DAMAGE; MITOGENESIS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTATE CANCER; STAINING;

ANDROGENS; APOPTOSIS; CLUSTERIN; DEOXYGUANOSINE; DIHYDROTESTOSTERONE; DNA DAMAGE; DNA, COMPLEMENTARY; GENE EXPRESSION; GLYCOPROTEINS; HUMANS; HYDROGEN PEROXIDE; LIPID PEROXIDATION; MALE; MOLECULAR CHAPERONES; NEOPLASMS, HORMONE-DEPENDENT; OXIDATIVE STRESS; PROSTATIC NEOPLASMS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 9444288705     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.20087     Document Type: Article

References (26)

1. Sakr WA, Grignon DJ, Haas GP, Heilbrun LK, Pontes JE, Crissman JD. Age and racial distribution of prostatic intraepithelial neoplasia. Eur Urol 1996;30:138-144.
2. Ripple MO, Henry WF, Rago PP, Wilding G. Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells. J Natl Cancer Inst 1997;89:40-48.
3. Baker M, Oberley LW, Cohen MB. Expression of antioxidant enzymes in human prostatic adenocarcinoma. Prostate 1997;32: 229-233.
4. Li N, Oberley TD, Oberley LW, Zhong W. Overexpression of manganese superoxide dismutase in DU145 human prostate carcinoma cells has multiple effects on cell phenotype. Prostate 1998;35:221-233.
5. Jones SE, Jomary C. Clusterin. Int J Biochem Cell Biol 2002;34: 427-431.
6. Connor J, Buttyan R, Olsson CA, D'Agati V, O'Toole K, Sawczuk IS. SGP-2 expression as a genetic marker of progressive cellular pathology in experimental hydronephrosis. Kidney Int 1991;39: 1098-1103.
7. Kyprianou N, English HF, Davidson NE, Isaacs JT. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res 1991;51:162-166.
8. Schwochau GB, Nath KA, Rosenberg ME. Clusterin protects against oxidative stress in vitro through aggregative and nonaggregative properties. Kidney Int 1998;53:1647-1653.
9. French LE, Wohlwend A, Sappino AP, Tschopp J, Schifferli JA. Distinct sites of production and deposition of the putative cell death marker clusterin in the human thymus. J Clin Invest 1994; 93:877-884.
10. Miyake H, Nelson C, Rennie PS, Cleave ME. Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen-independence in prostate cancer. Cancer Res 2000;60:170-176.
11. Miyake H, Nelson C, Rennie PS, Gleave ME. Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models. Cancer Res 2000;60:2547-2554.
12. Miyake H, Chi KN, Gleave ME. Antisense TRPM-2 oligodeoxynucleotides chemosensitize human androgen-independent PC-3 prostate cancer cells both in vitro and in vivo. Clin Cancer Res 2000;6:1655-1663.
13. Miyake H, Hara I, Kamidono S, Cleave ME. Synergistic chemosensitization and inhibition of tumor growth and metastasis by the antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model. Clin Cancer Res 2001; 6:4245-4252.
14. Miyake H, Hara S, Zellweger T, Kamidono S, Cleave M, Hara I. Acquisition of resistance to Fas-mediated apoptosis by overexpression of clusterin in human renal cell carcinoma cells. Mol Urol 2001;5:105-111.
15. Miyake H, Nelson C, Rennie PS, Cleave ME. Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3′-kinase pathway. Endocrinology 2000;141:2257-2265.
16. Nowzari FB, Davidson SD, Eshghi M, Mallouh C, Tazaki H, Konno S. Adverse effects of oxidative stress on renal cells and its prevention by antioxidants. Mol Urol 2000;4:15-19.
17. Erhola M, Toyokuni S, Okada K, Tanaka T, Hiai H, Ochi H, Uchida K, Osawa T, Nieminen MM, Alho H, Kellokumpu-Lehtinen P. Biomarker evidence of DNA oxidation in lung cancer patients: Association of urinary 8-hydroxy-2′- deoxyguanosine excretion with radiotherapy, chemotherapy, and response to treatment. FEBS Lett 1997;409:287-291.
18. Leinonen J, Lehtimaki T, Toyokuni S, Okada K, Tanaka T, Hiai H, Ochi H, Laippala P, Rantalaiho V, Wirta O, Pasternack A, Alho H. New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett 1997;417:150-152.
19. Tsuboi H, Kouda K, Takeuchi H, Takigawa M, Masamoto Y, Takeuchi M, Ochi H. 8-hydroxydeoxyguanosine in urine as an index of oxidative damage to DNA in the evaluation of atopic dermatitis. Br J Dermatol 1998;138:1033-1035.
20. Jikimoto T, Nishikubo Y, Koshiba M, Kanagawa S, Morinobu S, Morinobu A, Saura R, Mizuno K, Kondo S, Toyokuni S, Nakamura H, Yodoi J, Kumagai S. Thioredoxin as a biomarker for oxidative stress in patients with rheumatoid arthritis. Mol Immunol 2001;38:765-772.
21. Feig DI, Reid TM, Loeb LA. Reactive oxygen species in tumorigenesis. Cancer Res 1994;54:1890-1894.
22. Sun Y. Free radicals, antioxidant enzymes, and carcinogenesis. Free Radic Biol Med 1990;8:583-599.
23. Thompson IM, Colyman CA, Brawley OW, Ryan A. Chemoprevention of prostate cancer. Semin Urol 1995;13:122-129.
24. Wilding G. Endocrine control of prostate cancer. Cancer Surv 1995;23:43-62.
25. Fleshner N, Fair WR, Huryk R, Heston WD. Vitamin E inhibits the high-fat diet promoted growth of established human prostate LNCaP tumors in nude mice. J Urol 1999;161:1651-1654.
26. Chen L, Stacewicz-Sapuntzakis M, Duncan C, Sharifi R, Ghosh L, van Breeman R, Ashton D, Bowen PE. Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention. J Natl Cancer Inst 2001;93:1872-1879.